Raj Chovatiya, MD, PhD: Safety of Oral JAK Inhibitors for Atopic Dermatitis
Dr. Chovatiya discusses safety data on upadacitinib and abrocitinib for the treatment of atopic dermatitis.
Matthew Zirwas, MD: Dermatology Literature in Review 2023
In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Zirwas discusses some of the most exciting new papers published this year in atopic dermatitis research.
Victoria Lazareth, MA, MSN, NP-C, DCNP: Surgical Procedural Workshop
Victoria Lazareth discussed topics covered during the Surgical Procedural Workshop, which took place during the meeting’s Pre-Conference Day.
Douglas DiRuggiero, DMSc, PA-C: Benefits of Oral JAK Inhibitors for Atopic Dermatitis
Doug DiRuggiero discusses oral JAK inhibitors for patients with atopic dermatitis and how these new agents will benefit patients with AD.
Ted Rosen, MD: Infectious Disease Update 2023
In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Rosen overviews updates on COVID-19 and long COVID, monkeypox, HIV, and fungal infections.